The Portfolio Armor Substack

The Portfolio Armor Substack

Trade Alert: Solving Real-World Problems

Three bullish options trades tied to connected commerce, cancer care and cardiometabolic medicine.

Portfolio Armor's avatar
Portfolio Armor
Sep 10, 2026
∙ Paid

The Problems In Front Of Us

Will AI kill us all? We don’t think so, but we addressed that hysteria, and the money and politics behind it, in a free post earlier today.

The Campaign To Regulate AI

Portfolio Armor
·
10:54 AM
The Campaign To Regulate AI

The Warning And The Machinery Behind It

Read full story

Today’s trades focus on real problems in front of us. Cancer continues to demand better treatments. Cardiometabolic disease remains a vast medical burden. Companies still struggle to identify, locate and authenticate billions of physical items as they move through stores and supply chains.

Today’s three trades target businesses working on those problems. They came from three independent sources of alpha: Portfolio Armor’s Top Names, Our Multibaggers—the group of outside analysts we follow who’ve identified multiple stocks that gained 100% or more—and the Portfolio Armor subscriber community. Each trade passed our technical screens, which look for stocks in an uptrend where prices have consolidated a bit and the shares aren’t overextended.

New to our alerts? “Start Here” explains how we select trades, set entry prices and exits, and track every completed result.

Start Here

Aug 22
Start Here

How We Stack Multiple Edges

Read full story

Matching The Structure To The Opportunity

The Top Names trade is designed to capture Portfolio Armor’s estimated upside if the ranking proves right. The Multibaggers trade preserves uncapped exposure around a cluster of clinical readouts. The Portfolio Armor Community Trade uses a tighter payoff range suited to a steadier stock.

The ideas came from three independent sources, but each reached the same starting point: a strong technical setup. From there, we matched the structure to the stock’s behavior and catalyst path while keeping the downside defined.

Together, they offer three distinct ways to pursue upside: a growth name with a model-based target, a biotech with near-term catalysts and a pharmaceutical company with developmental exposure to a major therapeutic market.

Paid subscribers will find the company names, exact structures, maximum entry prices and pre-set exit orders below.

Today’s Top Names Trade

Theme: Item-level visibility across the physical economy.

RSI: 49 · Technical: 6/10 · Setup: 8/10 · Fundamental: 4/10

User's avatar

Continue reading this post for free, courtesy of Portfolio Armor.

Or purchase a paid subscription.
© 2026 Portfolio Armor · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture